Nurofen maker faces another legal headache
This story has been updated.
THE maker of Nurofen is facing another legal headache just months after losing a case in the Federal Court over a range of misleadingly labelled painkillers.
Reckitt Benckiser was ordered in December to pull four targeted pain products from the shelves on the grounds that they had mislead consumers because they all contained the same active ingredient: ibuprofen lysine 342mg.
Now law firm Bannister Law wants to recruit people who bought the products to join a class action.
“Our claim is for a full refund of the Nurofen specific pain